Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
731studies shown
Showing 101-125 of 731
RecruitingNCT07220460

Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder

This study is looking at assess how safe and effective ABBV-932 is in treating participants with depressive episodes associated with bipolar I or II disorder. Participants receive a study treatment and complete follow-up visits and assessments.

BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
AbbVie
Condition
Bipolarity
RecruitingNCT02604277

Suicidal Behavior in Patients Diagnosed With Bipolarity

This study is looking at learn the environmental and psychological factors that impact suicidality in patients diagnosed with bipolarity for people with Depression, Alcoholism, or Drug Abuse. Participants receive a study treatment and complete follow-up visits and assessments.

BipolarityBehavioralFrom 18 Years to 64 Years
Countries
United States
Sponsor
Emory University
Condition
Bipolarity
RecruitingNCT06700902

Taking Action for College Students

This study is looking at whether questionnaires and follow-up can help people with depression, bipolarity, or Schizophrenia. Participants take part in the program and complete follow-up questionnaires or assessments.

DepressionBehavioralOver 18 Years
Countries
United States
Sponsor
Temple University
Condition
Depression
RecruitingNCT05786066

The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects

This study is comparing Perampanel 6 MG with placebo for people with depression, bipolarity, Post Traumatic Stress Disorder, or Suicidal Ideation. Participants receive Perampanel 6 MG or placebo and complete study visits and assessments.

DepressionDrugFrom 21 Years to 65 Years
Countries
United States
Sponsor
Yale University
Condition
Depression
Active Not RecruitingNCT05172271

Transcranial Electric Stimulation Therapy (TEST) for Treatment Resistant Depression (TRD)

This study is comparing MagPro TMS Stimulator and coil with Sham TEST for people with depression, bipolarity, or Unipolar Major Depression. Participants receive MagPro TMS Stimulator and coil or Sham TEST and complete study visits and assessments.

DepressionDeviceFrom 25 Years to 64 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Depression
RecruitingNCT06373016

Use of Ketosis in Modulating Metabolic Pathways in Bipolarity

This study is looking at care and outcomes for people with bipolarity or bipolarity Type 1. Taking part may give some people access to Glucose, but direct benefit is not guaranteed.

BipolarityOtherFrom 18 Years to 45 Years
Countries
United States
Sponsor
Stony Brook University
Condition
Bipolarity
RecruitingNCT06462196

Natural History of Depression, Bipolarity and Suicide Risk

This study is looking at be conducted at the NIH Clinical Center in Bethesda, MD for people with depression or bipolarity. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

DepressionOtherFrom 18 Years to 120 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Depression
Active Not RecruitingNCT06002204

Studying the Health of Asians to Advance Knowledge, Treatments, and Interventions for Depression

This observational study is following people with Depression, Treatment Resistant Depression, bipolarity, or Mental Disorders to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

DepressionOtherOver 10 Years
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Condition
Depression
RecruitingNCT04480918

University of Iowa Interventional Psychiatry Service Patient Registry

This study is looking at examine the effects of interventional/procedural therapies for treatment-resistant depression (TRD) and Obsessive-Compulsive Disorder (OCD) for people with depression or bipolarity. Participants are followed over time so researchers can learn from clinical and follow-up information.

DepressionDeviceFrom 18 Years to 99 Years
Countries
United States
Sponsor
Mark Niciu
Condition
Depression
RecruitingNCT03748446

Xenon Inhalation Therapy for Major Depressive Disorder and Bipolarity

This study is comparing Xenon with placebo for people with depression or Depression in bipolarity. Participants receive Xenon or placebo and complete study visits and assessments.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Depression
Active Not RecruitingNCT03788811

ERG Components in Schizophrenia and Bipolarity type I

This study is looking at further assess ERG components obtained with different ERG devices, to be considered in a prediction model for each diagnosis for people with Schizophrenia or Bipolarity I. Participants are followed over time so researchers can learn from clinical and follow-up information.

BipolarityDeviceFrom 18 Years to 50 Years
Countries
United States, Australia, Canada
Sponsor
diaMentis Inc.
Condition
Bipolarity
RecruitingNCT06229210

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolarity or Autism Spectrum Disorder

This observational study is following people with Schizophrenia, bipolarity, or Autism Spectrum Disorder to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

BipolarityDrugFrom 5 Years to 17 Years
Countries
United States, Serbia
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Bipolarity
RecruitingNCT06911931

Visual Perception in Schizophrenia

This study is looking at identify novel markers of psychosis using electroencephalography (EEG) for people with Schizophrenia Disorders, bipolarity, or Schizo Affective Disorder. Taking part may give some people access to EEG measure of visual processing, but direct benefit is not guaranteed.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Rochester
Condition
Schizophrenia
RecruitingISRCTN44497123

Effects of personalized exercise training on physical activity, health-related fitness, sleep quality, and quality of life among middle-aged and older adults with multiple health problems

This study is looking at whether A randomized controlled trial with three groups was created can help people with Multimorbidity or Other. Participants take part in A randomized controlled trial with three groups was created and complete follow-up assessments.

SchizophreniaOther
Countries
Algeria, United States, Andorra, Angola, United Kingdom, Antarctica, Antigua and Barbuda, Argentina, Armenia, Netherlands, Taiwan
Sponsor
National Defense Medical Center
Condition
Schizophrenia
RecruitingISRCTN11314056

Can electrical stimulation reduce brain activity in brain regions involved in reward responses linked to risk-taking behavior in people with bipolarity?

This study is looking at care and outcomes for people with bipolarity or Mental and Behavioural Disorders. Some participants may receive sham treatment instead of the study treatment, and direct benefit is not guaranteed.

BipolarityOtherFrom 18 Years to 45 Years
Countries
United States
Sponsor
University of Pittsburgh
Condition
Bipolarity
RecruitingISRCTN21059161

Population-based Outreach Services to Reduce Homelessness among Veterans with serious mental illness (SMI)

This study is looking at whether Standard REP included the initial Implementation phase of Re-Engage, specifically: 1 can help people with Serious mental illnesses including schizophrenia, bipolarity, and schizoaffective disorder, Mental and Behavioural Disorders, or Schizophrenia, Bipolarity. Participants take part in Standard REP included the initial Implementation phase of Re-Engage, specifically: 1 and complete follow-up assessments.

SchizophreniaOther
Countries
United States
Sponsor
VA Health Services Research & Development (USA)
Condition
Schizophrenia
RecruitingISRCTN97160532

SMRI-02T-162A: double blind placebo controlled trial of a protein kinase C inhibitor: tamoxifen citrate in treatment of acute mania

This study is looking at whether a digital support tool can help people with bipolarity-I, most recent episode manic or mixed, with or without psychotic features, Mental and Behavioural Disorders, or bipolarity. Participants receive a study treatment and complete follow-up visits and assessments.

BipolarityOtherOver 18 Years
Countries
Turkey, United States
Sponsor
The Stanley Medical Research Institute (SMRI) (USA)
Condition
Bipolarity
Bipolarity | Clinical Trials | HopeStage Research